Study Links Pradaxa Bleeding in Patients Taking Medicine
Pradaxa News: Research Reveals Pradaxa Bleeding in Patients Taking Medicine
When Pradaxa was approved by the FDA in 2010, it was touted as a safer alternative to other blood thinning medications, which help prevent strokes. But just one year later, the drug was linked to more deaths in the U.S. than any other prescription medication. In 2012, a study showed that Pradaxa increases the risk of heart attack by 33 percent. And a new study from Denmark shows that patients who switch to Pradaxa from other blood-thinning medications have a high risk of internal bleeding.
Although Pradaxa bleeding is not “new” news – the FDA has issued several Drug Safety Communications about the link between Pradaxa and bleeding disorders – this latest study could provide additional support to the already growing number of Pradaxa lawsuits being filed in the U.S.
Another study published by the Journal of Neurosurgery this past May came to similar conclusions about Pradaxa bleeding. In this study, it was found that people who take Pradaxa could die from brain bleeding if experience a head trauma. The same study noted that once Pradaxa causes internal bleeding, there is little a doctor can do to stop it.
Damaging news of Pradaxa bleeding and other side effects have already led to a swell of new lawsuits. The past year has seen a 50 percent growth in the number of lawsuits filed against Boehringer, the maker of Pradaxa, and that number is expected to continue climbing.
If you or someone you know are taking Pradaxa and have had a heart attack or serious internal bleeding, talk to a lawyer at 1-800-THE-LAW2. Our Pradaxa lawyers are reviewing claims that could lead to significant financial compensation.
With 1-800-THE-LAW2, you can get the legal representation you need without paying a dime out-of-pocket.